BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12866370)

  • 1. Comparison of three methods for measuring factor VIII levels in plasma.
    Chandler WL; Ferrell C; Lee J; Tun T; Kha H
    Am J Clin Pathol; 2003 Jul; 120(1):34-9. PubMed ID: 12866370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of factor VIII deficiency.
    Verbruggen B; Meijer P; Novákova I; Van Heerde W
    Haemophilia; 2008 Jul; 14 Suppl 3():76-82. PubMed ID: 18510526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application of a chromogenic substrate method for determination of factor VIII activity.
    Rosén S; Andersson M; Blombäck M; Hägglund U; Larrieu MJ; Wolf M; Boyer C; Rothschild C; Nilsson IM; Sjörin E
    Thromb Haemost; 1985 Dec; 54(4):818-23. PubMed ID: 3937277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].
    Lutze G; Lutze G; Kutschmann K; Schröpel M
    Berl Munch Tierarztl Wochenschr; 2002; 115(7-8):297-302. PubMed ID: 12174728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. comparison of clot-based vs chromogenic factor Xa procoagulant phospholipid activity assays.
    Bohling SD; Pagano MB; Stitzel MR; Ferrell C; Yeung W; Chandler WL
    Am J Clin Pathol; 2012 Feb; 137(2):185-92. PubMed ID: 22261442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rebuttal: Issues with the assay of factor VIII activity in plasma and factor VII concentrates.
    Rosén S
    Thromb Haemost; 2001 Oct; 86(4):1132-3. PubMed ID: 11686346
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
    Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
    Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chromogenic assay allows reliable measurement of factor VIII levels in the presence of strong lupus anticoagulants.
    de Maistre E; Wahl D; Perret-Guillaume C; Regnault V; Clarac S; Briquel ME; Andre E; Lecompte T
    Thromb Haemost; 1998 Jan; 79(1):237-8. PubMed ID: 9459356
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a new venom-based clotting assay of protein C.
    Cooper PC; Cooper SM; Goodfellow KJ; Hickey KP; Kitchen S; Makris M
    Int J Lab Hematol; 2008 Oct; 30(5):437-43. PubMed ID: 19046320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation and chromogenic assays of factor VIII activity: general aspects, standardization, and recommendations.
    Barrowcliffe TW; Raut S; Sands D; Hubbard AR
    Semin Thromb Hemost; 2002 Jun; 28(3):247-56. PubMed ID: 12098084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and performance characteristics of the automated coagulation analyzer ACL TOP.
    Appert-Flory A; Fischer F; Jambou D; Toulon P
    Thromb Res; 2007; 120(5):733-43. PubMed ID: 17275069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monitoring of plasma concentration of low molecular weight heparin--comparative evaluation with chromogenic and clotting assays].
    Katagiri H; Itoh S; Uchida T; Kawai Y; Watanabe K
    Rinsho Byori; 1999 Nov; 47(11):1046-51. PubMed ID: 10590682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
    Kitchen S; Theaker J; Preston FE
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A collaborative study to establish a Korean Standard for factor VIII:C concentrate.
    Kang HN; Kim SN; Lee SH; Hong SH
    Thromb Res; 2004; 113(3-4):261-7. PubMed ID: 15140591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the automated coagulation analyzer Sysmex CA-7000.
    Fischer F; Appert-Flory A; Jambou D; Toulon P
    Thromb Res; 2006; 117(6):721-9. PubMed ID: 16098565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
    Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of agreement of chromogenic and clotting assays for factor X and protein C in warfarinised plasma.
    Han P; Fung KP; Rahdakrishnan U
    Thromb Haemost; 1991 Apr; 65(4):360-3. PubMed ID: 2057917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of chromogenic vs clot.based one stage APTT assay for determination of factor VIII level.
    Baig MA; Swamy KB
    Indian J Pathol Microbiol; 2021; 64(1):123-127. PubMed ID: 33433421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.